Coherus Inks $300m Credit Agreement With Ranibizumab Approval Worth $50m

US Biotech Also Reveals Latest Progress With On-Body Pegfilgrastim Injector

 
• By Dean Rudge
  
Dollar bills
Coherus is eyeing up to five launches by 2023 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business